4//SEC Filing
GENEREX BIOTECHNOLOGY CORP 4
Accession 0001554795-13-000645
CIK 0001059784operating
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 4:37 PM ET
Size
5.7 KB
Accession
0001554795-13-000645
Insider Transaction Report
Form 4
Brusegard David
Chief Operating Officer
Transactions
- Award
Common Stock Purchase Option (right to buy)
2013-10-31+845,492→ 845,492 totalExercise: $0.00From: 2014-01-01Exp: 2018-10-31→ Common Stock (845,492 underlying)
Footnotes (1)
- [F1]On October 31, 2013, the Board of Directors of the issuer granted the reporting person options to purchase 845,492 shares of the issuer's common stock in lieu of cash payment of deferred compensation, which grant was effective upon the reporting person's execution of a Settlement and Release Agreement with the issuer effective October 31, 2013. The grant was made pursuant to the terms of the issuer's 2006 stock plan (445,492 options) and the 2001 stock plan (400,000 options).
Documents
Issuer
GENEREX BIOTECHNOLOGY CORP
CIK 0001059784
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001059784
Filing Metadata
- Form type
- 4
- Filed
- Oct 31, 8:00 PM ET
- Accepted
- Nov 1, 4:37 PM ET
- Size
- 5.7 KB